Navigation Links
NIOXIN(R) Delivers the Future to Scalp and Hair Care, Introduces the First Genetic Test to Determine the Likelihood of Hair Loss
Date:3/6/2008

Leading Scalp and Hair Care Company Enters Agreement with HairDX to Offer

Consumer-Friendly Hair Loss Test

ATLANTA, March 6 /PRNewswire/ -- NIOXIN(R) Research Laboratories Inc., the leader in professional skincare for the scalp, today announced that it will offer an easy to access and understand genetic test that determines the likelihood of developing male pattern baldness -- before it actually begins to happen. Similarly, a test for women is being developed and may be available soon.

NIOXIN(R) has entered into an agreement with HairDX, a biotech start-up based in Irvine, CA, to offer the test as part of its next generation effort in introducing scientifically proven scalp and hair products. HairDX is the first genome test to be made available to consumers in helping assess their risk and genetic predisposition for developing pattern baldness (Androgenetic Alopecia). This new genetic test is accessible through the internet at http://www.nioxin.com and will be promoted at consumer education events held nationally beginning March 1st 2008.

According to the American Hair Loss Association, by the age of 35, two-thirds of American men will experience some degree of appreciable hair loss and by the age of 50, approximately 85% of men will have significantly thinning hair.

"Gaining a better understanding of the potential cause of an individual's condition enables a more accurate assessment of the most appropriate solution," said Eva Graham, founder of NIOXIN(R) Research Laboratories, Inc.

"HairDX is proud to work with NIOXIN(R) to help genetic science make a positive contribution to scalp and hair care," said Andy Goren, CEO of HairDX. "This provides a personalized profile for many individuals who can benefit from knowing their risk of hair loss and allow them to take action early, before the condition becomes severe."

HOW IT WORKS:

The participant simply swabs their mouth (inside cheek) for several seconds and returns the swab in a sealed pack to the HairDX lab. HairDX performs a confidential and anonymous genetic analysis of the individual's genetic variations related to pattern baldness. The confidential results are delivered via a secure Web site.

"HairDX tests for a genetic variant found in more than 95% of bald men. 60% of patients with this variant experienced male pattern baldness before the age of 40, thus it is a marker for a significant increased risk of pattern baldness," says Professor Doron Lancet, PhD, a pioneer of genome research and Head of the Crown Human Genome Center at the Department of Molecular Genetics, Weizmann Institute of Science in Rehovot, Israel. "This is in contrast to the less common genetic variant of the same gene, present in about 1 in 6 people, which indicates greater than 85% likelihood that a person will not experience early onset pattern baldness."

About HairDX

Based in Irvine, CA, HairDX was founded by leading researchers and specialists in genetic analysis and hair therapies. The company is dedicated to helping people make the right decisions about hair care, treatment and restoration by providing accurate and accessible personalized scientific information.

Among HairDX founders is William V. Murray former Division President of the Molecular Biology Division of Applied BioSystems, Inc., who formerly served in various executive leadership positions within Medtronic; Andy Goren former CEO of MobileWise, Inc. and GeePS, Inc.; Eran Goren, CEO of enCircle Media, Inc.; Professor Doron Lancet, PhD, Head of the Crown Human Genome Center at the Department of Molecular Genetics, Weizmann Institute of Science; Dr. Peter Novak, a Neurologist at the University of Massachusetts Medical Center; Elliott J. Stein, an intellectual property attorney and co-founder of GeePS, Inc. and Mace Wolf. HairDX, LLC is a subsidiary of myGenopedia, Inc. More information is available at http://www.hairdx.com.

About NIOXIN Research Laboratories Inc.

NIOXIN(R) is the leading provider of advanced skincare solutions that treat the scalp to improve the appearance of fine and thinning hair. Founded in 1987 by Eva Graham, this privately-held company has been dedicated to providing education and products for consumers through the professional salon industry around the world. Distributed in more than 42 countries on six continents, NIOXIN(R) continues to define the meaning of innovation and leadership for the global market of fine and thinning hair. Additional information is available at http://www.nioxin.com or at 800-789-9617.

Contact: Rebecca Levy for NIOXIN PR

rlevy@bratskeir.com

212-679-2233


'/>"/>
SOURCE NIOXIN Research Laboratories Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. CompareNetworks Media Group Delivers CME/CE Through Acuity Medical Education
2. Nikon Instruments New NIS-Elements C Delivers Comprehensive Confocal and Widefield Imaging Capabilities in Single Unifying Software Platform
3. Millennium Over-Delivers on 2007 Goals and Financial Guidance
4. Novel Angiogenic Drugs, Including a Future Blockbuster from Genzyme, Could Revolutionize Treatment of Peripheral Arterial Disease
5. Advancements in Population Age and Technology Drive Future of Orthopedic Materials Market
6. Coherent Sets Future Financial Target
7. Nanotube forests grown on silicon chips for future computers, electronics
8. Growing tiny carbon nanotube wires to connect computer chips of the future
9. Solar cells of the future
10. NASA technology helps predict and prevent future pandemic outbreaks
11. Carrington Settles Lawsuit, Sets Sights On Future
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... Calif. , June 23, 2016  The Prostate Cancer Foundation ... increasingly precise treatments and faster cures for prostate cancer. Members of the Class ... across 15 countries. Read More About the Class of ... ... ...
(Date:6/23/2016)... ... June 23, 2016 , ... In a new case report ... detail how a patient who developed lymphedema after being treated for breast cancer benefitted ... change the paradigm for dealing with this debilitating, frequent side effect of cancer treatment. ...
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, the only free ... and will showcase its product’s latest features from June 26 to June 30, ... poster on Disrupting Clinical Trials in The Cloud during the conference. DIA ...
(Date:6/22/2016)... SAN DIEGO , June 22, 2016 /PRNewswire/ ... partnership that will allow them to produce up ... (HiPSC) from one lot within one week. These ... their time laboriously preparing cells and spend more ... made possible through a proprietary, high-volume manufacturing process ...
Breaking Biology Technology:
(Date:5/12/2016)... , May 12, 2016 WearablesResearch.com , ... published the overview results from the Q1 wave of ... recent wave was consumers, receptivity to a program where ... with a health insurance company. "We were ... share," says Michael LaColla , CEO of Troubadour ...
(Date:4/28/2016)... and BANGALORE, India , April 28, ... Systems, a product subsidiary of Infosys (NYSE: INFY ... announced a global partnership that will provide end ... use mobile banking and payment services.      (Logo: ... key innovation area for financial services, but it also plays ...
(Date:4/26/2016)... , April 27, 2016 ... "Global Multi-modal Biometrics Market 2016-2020"  report to their ... , The analysts forecast the global ... of 15.49% during the period 2016-2020.  ... of sectors such as the healthcare, BFSI, transportation, ...
Breaking Biology News(10 mins):